Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Brown Adipocyte Sheets Alleviate Myocardial Ischemia-Reperfusion Injury Through NRG4-ErbB4-Dependent Ferroptosis Inhibition.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

Diabetes and Vitiligo.

Diabetes care·2026

Same author

Serum 25-hydroxyvitamin D and adult-onset atopic dermatitis: insights from two large national cohorts.

Food & function·2026

Same author

Normalized creatinine-to-cystatin C ratio and atherosclerotic cardiovascular disease risk in the UK Biobank.

European journal of preventive cardiology·2026

Same author

Association Between Serum Micronutrients and Advanced CKM Syndrome: An Interpretable Machine Learning-Based Study.

Food science & nutrition·2025

Same author

Mechanical Performance of Engineered Heart Tissue Can Be Measured with POC-Based Video Analysis.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025

Search research articles

Related Experiment Video

Updated: Aug 22, 2025

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Published on: June 9, 2020

Engineered Tissue for Cardiac Regeneration: Current Status and Future Perspectives.

Junjun Li¹, Li Liu¹, Jingbo Zhang¹

¹Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.

Bioengineering (Basel, Switzerland)

|November 10, 2022

Summary

This summary is machine-generated.

Human pluripotent stem cell-derived cardiomyocytes offer a promising solution for heart failure, addressing donor heart shortages. Tissue engineering advances are paving the way for their clinical use in heart transplantation.

Keywords:

cardiac regeneration cardiomyocytes heart failure human induced pluripotent stem cells tissue engineering

More Related Videos

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Published on: October 3, 2014

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Related Experiment Videos

Last Updated: Aug 22, 2025

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Published on: June 9, 2020

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets

Published on: October 3, 2014

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Area of Science:

Regenerative Medicine
Cardiovascular Research
Biomaterials Science

Background:

Heart failure (HF) is a major global health concern, with limited donor hearts restricting transplantation efficacy.
Human pluripotent stem cells (hPSCs), including embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs), can be generated indefinitely.
hPSCs can be efficiently differentiated into cardiomyocytes (hPSC-CMs), presenting a potential alternative to donor hearts.

Purpose of the Study:

To review tissue-engineering technologies for human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs).
To discuss materials, formation techniques, and delivery methods for hPSC-CMs in cardiac repair.
To highlight recent clinical applications and future challenges for hPSC-CM translation.

Main Methods:

Review of literature on hPSC-CM generation and differentiation.
Analysis of biomaterials and scaffold techniques for cardiac tissue engineering.
Examination of delivery strategies for hPSC-CMs into cardiac tissue.
Assessment of current clinical trial data and regulatory pathways.

Main Results:

hPSC-CMs show high differentiation efficiency and potential for cardiac regeneration.
Various biomaterials and tissue engineering strategies are being developed to support hPSC-CM survival and function.
Delivery methods are advancing, with initial clinical applications showing promise.
Significant progress has been made in harnessing hPSC-CMs for therapeutic purposes.

Conclusions:

hPSC-CMs represent a viable alternative to donor hearts for treating heart failure.
Tissue engineering innovations are crucial for the successful clinical translation of hPSC-CMs.
Overcoming current limitations and continued research are essential for widespread adoption in cardiac repair.